Adalimumab Demonstrates Long-Term Benefit in Ankylosing ... - DG News

Adalimumab Demonstrates Long-Term Benefit in Ankylosing ... DG News - Jun 15, 2008 By Jill Stein PARIS -- June 15, 2008 -- Adalimumab safely decreases symptoms of ankylosing spondylitis (AS), with results maintained for up to 3 years, ... Adalimumab Cuts Uveitis Flares: Presented at EULAR DG News all 2 news articles

Adalimumab Effective in Patients With Rheumatic Disease ... - DG News

Adalimumab Effective in Patients With Rheumatic Disease ... DG News - Jun 13, 2008 There were 1250 AS patients in the RHAPSODY (Review of Safety and Effectiveness With Adalimumab in Patients With Active Ankylosing Spondylitis) trial; ...

New Self-Management Programme Offers Significant Benefits For ... - Medical News Today (press release)

New Self-Management Programme Offers Significant Benefits For ... Medical News Today (press release), UK - Jun 13, 2008 After 12 weeks of treatment with adalimumab, AS patients were found to have a mean reduction in BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) ...